ARCHIVES

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

This article is from The Cancer Letter archive.

Vol. 35 No. 29 | July 24, 2009

Download PDF Visit The Full Archive

Related Articles

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

April 2, 1999

Workers Ignorant Of Benzidine Risk, Union tells Congress

April 3, 1987

NCI Staff Working Group Leans Toward Starting COP With Community Hospitals As Lead Funding Agencies

January 1, 1982

Upton Briefed On Problems; To Start July 25

July 15, 1977

Q&A With The Cancer Letter: MD Anderson Provost Had No Say

May 25, 2012

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

June 2, 2006